18 This reduced contractility is most likely the net result of a number of changes in the hearts of hypertensive animals. Depressed cAMP-dependant Ca 1+ transport has been described in the cardiac sarcoplasmic reticulum of spontaneously hypertensive rats. 4 Hearts of spontaneously hypertensive animals also contain a reduced concentration of cAMP, s and cardiac membranes from DOCA-salt and renal as well as spontaneously hypertensive animals show a reduced isoproterenol stimulation of adenylate cyclase activity."
T HE myocardium of hypertensive animals has a reduced inotropic and chronotropic response to adrenergic stimulation. 18 This reduced contractility is most likely the net result of a number of changes in the hearts of hypertensive animals. Depressed cAMP-dependant Ca 1+ transport has been described in the cardiac sarcoplasmic reticulum of spontaneously hypertensive rats. 4 Hearts of spontaneously hypertensive animals also contain a reduced concentration of cAMP, s and cardiac membranes from DOCA-salt and renal as well as spontaneously hypertensive animals show a reduced isoproterenol stimulation of adenylate cyclase activity."
Recent studies have demonstrated decreased concentrations of /9-adrenergic receptors in the myocardium of hypertensive animals. 710 To determine whether these changes are specific to /9-adrenergic receptors, cardiac a-adrenergic receptors have also been measured in hearts from renal hypertensive rats.
Depression of .myocardial adrenergic receptors may be part of a generally reduced adrenergic receptor concentration caused by the raised plasma catecholamine levels found in renal hypertensive rats. 11 Alternatively, it may result from a specific increase in cardiac sympathetic drive demonstrated in renal hypertensive rats. 12 To distinguish between these two mechanisms, /3 receptors have been measured in kidneys and lungs as well as in hearts of renal hypertensive rats.
Materials and Methods
We obtained [ Male Sprague-Dawley rats weighing 70-90 g were anesthetized with ether. The right kidney was removed. The left renal artery was dissected free, and a silver clip 2 mm wide with a 0.2 mm gap was used to constrict the artery. 18 Control rats were unilaterally nephrectomized and the left renal artery dissected free but not clipped. Systolic blood pressure of conscious animals was measured by a tail plethysmographic method.
Membrane Preparation
Rats were killed by cervical dislocation. Tissues were removed immediately, trimmed, and washed in 0.9% saline at 0°C. Tissues were minced with scissors and homogenized with a Potter/Elvejhem homogenizer in 3-5 vol of the appropriate buffer containing 0. 25 
Cardiac Alpha Receptors
The method used was similar to that described by Williams and Lefkowitz." Cardiac membranes (0.05 ml) were incubated with ['H]-DHE for 20 minutes at 25°C in a total volume of 0.15 ml containing 50 mM tris, pH 7.7, 10 mM Mg Cl,, 0.05% ascorbic acid. Binding was terminated by filtration and the filters were washed with 10 ml of buffer. Filters were dried and counted using a triton X-100/toluene scintillation fluid in a Packard liquid scintillation spectrometer.
Specific binding was defined as ['H]-DHE bound that
was displaceable by lO^M phentolamine. Specific binding ranged from 40%-70% of the total counts bound per filter. Results were analyzed by the method of Scatchard."
Renal and Pulmonary Beta Receptors
Membranes were incubated with ['HJ-DHA for 10 minutes at 37°C in a total volume of 0.2 ml containing 50 mM tris, pH 8.1, 10 mM MgCl,, 0.05% ascorbic acid, 10^M pyrocatechol, 10^M phentolamine. After termination of binding by filtration, filters were washed with 10 ml of ice-cold buffer. Specific binding was defined as binding displaced by 10~*M isoproterenol and ranged from 40%-60% in renal membranes and from 9O%-95% in pulmonary membranes. Results were analyzed by the method of Scatchard.
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Measurement of Plasma Membrane Marker Enzyme Activities
The method of Kidwai et al." was used to measure 5'-nucleotidase and ouabain-inhibited p-nitrophenylphosphatase. Ouabain-inhibited activity was taken as the difference between incubations containing 10 5 M ouabain and those containing no inhibitor. Adenylate cyclase was measured as described by Harden et al.1" using 'H-labelled ATP as substrate. Separation of cAMP was achieved by the method of Krishna et al. 19 Figure 1 shows the systolic blood pressures and heart weights of rats with a renal artery clip and their appropriate controls. Clipped animals developed consistent and comparable increases in blood pressure and ventricular weight. Receptor measurements were made 3 weeks after surgery when the blood pressure elevation was stable.
Results

Blood Pressures and Cardiac Hypertrophy of Hypertensive Rats
Characterization of Alpha-and Beta-Receptor Binding Sites
Cardiac Alpha Receptors
Binding of [*H]-DHE to myocardial membranes was saturable, rapid, and rapidly reversible. Stereospecificity was demonstrated by the 10-50-times-greater potency of L-epinephrine than Depinephrine in competing for specific binding sites. The order of potency of catecholamines in inhibiting [*H]-DHE binding was in agreement with a-receptor activity; thus, norepinephrine = epinephrine > > isoproterenol = dopamine. The relative potencies of agonist and antagonist compounds are listed in 
Receptor Changes in Renal Hypertensive Rats
Cardiac Alpha and Beta Receptors
Myocardial membranes prepared from hypertensive animals contained lower concentrations of both a and 0 receptors than membranes from control animals. The affinities of the receptors were unchanged. Figures 2 and 3 
Renal and Pulmonary Beta Receptors
No change in either concentration or affinity of /3 receptors was found in renal and pulmonary membranes from renal hypertensive rats. Results are summarized in table 2. 
. fHJ-dihydroergocryptine (fHJ-DHE) binding to myocardial membTanes fronf control and renal hypertensive rats. Scatchard analysis of the binding data expressed as the ratio of fHJ-DHE bound fmol/mg protein) to [*HJ-DHE free (mollliter) plotted against increasing fHJ-DHE bound (fmol/mg protein).
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Plasma Membrane Marker Enzyme Activities In Cardiac Membranes from Hypertensire Rats and Controls
The observed changes in myocardial adrenergic receptors may be part of a generalized decrease in plasma membrane components in hypertrophied hearts. Accordingly, plasma membrane marker enzyme activities were measured in membranes prepared from both normal and hypertrophied hearts. Activities of ouabain-sensitive phosphatase, 5'-nucleotidase, and basal adenylate cyclase are shown in table 3. The activities of each of these enzymes were similar in membranes prepared from control and hypertensive animals. The results suggest that the diminished number of a and # receptors from hypertrophied myocardium is a specific deletion effect and not the result of nonspecific dilution by cardiac hypertrophy.
Discussion
The myocardium of DOCA-salt hypertensive, renal hypertensive, and spontaneously hypertensive rats has a reduced concentration of /5-adrenergic receptors. The results of our experiments show that the number of a receptors is also reduced in hypertrophied hearts from rats with renal hypertension. Both a and 0 receptors were reduced by 40%-50%, a reduction similar to that reported previously for cardiac 0 receptors in DOCA-salt hypertensive rats 8 -" and spontaneously hypertensive rats. Adrenergic receptors can be modulated by other hormones as well as by adrenergic agonists. In general, other hormones have been reported to produce differential effects on the a-and /9-receptor populations. Thus, estrogen treatment increases a receptors but not 0 receptors in rabbit uterus," and cortisol reduces liver /9 receptors but not a receptors in adrenalectomized rats.* 8 Thyroid hormones affect cardiac a and 0 receptors in reciprocal fashion; thyroxine treatment causes an increase in 0 receptors and a decrease in a receptors."-u The similarity in the magnitude of the reductions in a and 0 receptors, however, suggests a common causative mechanism in renal hypertension where cardiac a-and /S-receptor concentrations decreased to a similar degree. It is likely that the receptor reduction is associated with increased stimulation by adrenergic agonists. It is of interest that a and /? receptors of the rat salivary gland were found to increase to a similar extent after chemical sympathectomy." The lack of any detectable change in renal and pulmonary 0 receptors suggest that the specific changes observed solely in the heart are not caused by raised circulating plasma catecholamine levels in renal hypertensive rats, 11 but are more likely associated with the increased cardiac sympathetic drive reported in experimental renal hypertension.
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The failure to detect any differences in the hypertrophied hearts, in the activities of three different enzymes commonly associated predominantly with the plasma membrane, suggests that the deletion of adrenergic receptors is a specific effect and rules out the possibility that the decrease is a dilutional effect from cardiac hypertrophy or an artifact of membrane preparation from hypertrophied hearts. Experiments are being conducted to determine whether the changes in adrenergic receptors precede or parallel the development of cardiac hypertrophy.
Since retention of sodium has been shown to occur in one-kidney, one clip Goldblatt hypertension,
80
-" an alternative explanation might be that the receptor changes are mediated by increased sodium. We have previously reported similarly decreased cardiac 0 receptors in DOCA-salt and one-kidney, one clip hypertensive rats, further suggesting a role for sodium. 8 -* The control unilaterally nephrectomized rats used in those experiments, however, had similar cardiac /9-receptor concentrations even though the DOCA-salt controls were sodium-loaded. This suggests that increased sodium is not a direct cause of the observed receptor changes.
Since the physiological role of cardiac a receptors is uncertain, it is difficult to assess the significance of a decrease in their concentration. According to Langer 81 and Guicheney et al., 10 approximately 30%-40% of rat heart a receptors are presynaptic. The observed decrease in cardiac a receptors may thus involve cither the presynaptic or postsynaptic receptors or both. It is not known whether presynaptic receptor numbers can also be modulated by agonist concentration. A recent report by Crewes and Smith," however, shows that the responsiveness of cardiac presynaptic a receptors is decreased by chronic treatment with desipramine, which increases synaptic norepinephrine concentration. Since the presynaptic and postsynaptic a receptors have different sensitivities to adrenergic drugs, it is possible to distinguish between them by direct binding methods." We are currently investigating the possibility of changes in the numbers of pre-and postsynaptic alpha receptors in cardiac membranes from hypertensive rats.
